Acquired hemophilia A (AHA) is due to autoantibodies against coagulation factor VIII (FVIII)
and most often presents with unexpected bleeding. In contrast to congenital hemophilia, the …

Acquired hemophilia A (AHA), a rare bleeding disorder caused by neutralizing
autoantibodies against coagulation factor VIII (FVIII), occurs in both men and women without …

Abstract Background Acquired hemophilia A (AHA) is a rare bleeding disorder caused by an
autoantibody to coagulation factor (F) VIII. It is characterized by soft tissue bleeding in …

Acquired haemophilia is a potentially life‐threatening bleeding disorder caused by the
development of autoantibodies against coagulation factors, most commonly against factor …

Acquired hemophilia A is a rare bleeding disorder caused by autoantibodies to coagulation
FVIII. Bleeding episodes at presentation are spontaneous and severe in most cases. Optimal …

Acquired hemophilia A (AHA) is a rare autoimmune disease caused by autoantibodies
inhibiting the function of coagulation factor VIII. It is characterized by spontaneous bleeding …

ABSTRACT Objectives: Acquired hemophilia A (AHA) is a rare, but potentially life-
threatening, bleeding disorder caused by an autoantibody against factor VIII that interferes …

Acquired hemophilia A is a bleeding disorder caused by antibodies to factor VIII (FVIII).
These antibodies—called inhibitors—interfere with normal hemostasis, leading to potentially …

In acquired hemophilia A (AHA), autoantibodies to coagulation factor VIII (FVIII) neutralize
FVIII activity leading to a potentially severe bleeding diathesis that carries a high rate of …

Autoantibodies against plasma coagulation factors could be developed by some individuals
inducing severe and sometimes fatal bleedings. This clinical entity is called acquired …